A researcher said on April
9 that so little is known about how plant estrogens act on the human body
that sales of soy supplements as a natural alternative to hormone replacement
therapy (HRT) must be questioned.
Soy is being widely promoted
as a natural alternative to HRT. This is because it contains genistein,
a plant estrogen that has similar but weaker effects to normal estrogen
found in women.
But Dr. Saffron Whitehead,
reader in reproductive physiology at St. George's Hospital Medical School,
London, said new studies on human cells have shown that genistein
and other phyto-estrogens may also stop the enzymes that make these hormones.
This could explain why the
incidence of breast cancer, which in many cases is dependent on estrogen,
is about two-thirds lower amongst Japanese and Chinese women who consume
diets rich in soy compared with women living in England.
Whitehead's team examined the
effects of phyto-estrogens on human ovarian cells obtained during procedures
for in vitro fertilization.
The results showed that several
phyto-estrogens, including genistein, inhibited the conversion of androgens
to estrogens.
The researchers believe this
could be significant in postmenopausal women because as these women's
ovaries cease to function, their only source of estrogens is converting
androgens released by their adrenal glands.
"This finding is potentially
important to the phyto-estrogen story," Whitehead added in a statement.
"We really don't know how phyto-estrogens act in the human body.
They could be weak estrogen mimics, estrogen blockers or enzyme inhibitors.
"If
they do stop the natural production of estrogens, we should consider whether
soy supplements be sold as a natural alternative to HRT."
Annual
Meeting British Endocrine Society's in Harrogate, Yorkshire England April
9, 2002
|